Matthew J. Hamilton

Development of goose- and duck-specific DNA markers to determine sources of Escherichia coli in waterways.

High-throughput and quantitative procedure for determining sources of Escherichia coli in waterways by using host-specific DNA marker genes.

Refractory Clostridium difficile-associated diarrhea.

Stress in the ER leads to inflammatory bowel disease.

Large scale analysis of virulence genes in Escherichia coli strains isolated from Avalon Bay, CA.

Gastric involvement in autoimmune pancreatitis: MDCT and histopathologic features.

Essential role for mast cell tryptase in acute experimental colitis.

Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations.

Adenocarcinoma complicating ulcerative colitis presenting as multiple pseudopolyp-like lesions.

Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance.

The population structure of Escherichia coli isolated from subtropical and temperate soils.

Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection.

The valuable role of endoscopy in inflammatory bowel disease.

Ras guanine nucleotide-releasing protein-4 (RasGRP4) involvement in experimental arthritis and colitis.

Immunology and clinical manifestations of non-clonal mast cell activation syndrome.

High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria.

Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation.

Comparative study of children and adolescents referred for eating disorder treatment at a specialist tertiary setting.

Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.

Restoring the gut microbiome for the treatment of inflammatory bowel diseases.

Importance of mast cell Prss31/transmembrane tryptase/tryptase-γ in lung function and experimental chronic obstructive pulmonary disease and colitis.

Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation.

The multifaceted mast cell in inflammatory bowel disease.

Development of Fecal Microbiota Transplantation Suitable for Mainstream Medicine.